SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-09-003667
Filing Date
2009-05-07
Accepted
2009-05-07 09:19:33
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 CORNERSTONE THERAPEUTICS INC. b75218cte10vq.htm 10-Q 605063
2 EX-10.1 AMENDMENT NO. 2, DATED MAY 4, 2009, TO CO-PROMOTION AND MARKETING SERVIC b75218ctexv10w1.htm EX-10.1 75345
3 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 b75218ctexv31w1.htm EX-31.1 8232
4 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 b75218ctexv31w2.htm EX-31.2 8517
5 EX-32.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 b75218ctexv32w1.htm EX-32.1 4498
6 EX-32.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 b75218ctexv32w2.htm EX-32.2 4542
  Complete submission text file 0000950135-09-003667.txt   707738
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 09803727
SIC: 2834 Pharmaceutical Preparations